CSL set to invest $313m to bulk up flu, COVID-19 mRNA tech
MELBOURNE: Blood products giant CSL is investing at least $US200 million ($313 million) ... read more
MELBOURNE: Blood products giant CSL is investing at least $US200 million ($313 million) ... read more